The Incremental Role of Coronary Computed Tomography in Chronic Coronary Syndromes

Baessato, Francesca; Guglielmo, Marco; Muscogiuri, Giuseppe; Baggiano, Andrea; Fusini, Laura; Scafuri, Stefano; Babbaro, Mario; Mollace, Rocco; Collevecchio, Ada; Guaricci, Andrea Igoren; Rabbat, Mark; D’Andrea, Antonello

doi:10.3390/jcm9123925

Cited by 18 publications

(22 citation statements)

References 136 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the evidence summarised in the previous paragraphs clearly highlights the pivotal role gained by cCTA in the management of patients with suspected CAD and pre-test probability other than very low. Importantly, this approach is feasible when the technique is easily and rapidly available, with access to the last-generation scanners (good diagnostic performance and minimised radiation exposure), with affordable cost by the patient or local health system, and with highly trained physicians [109,110].…”

Section: Proposed Management Algorithm For Patient With Suspected Cadmentioning

confidence: 99%

Changing Paradigms in the Diagnosis of Ischemic Heart Disease by Multimodality Imaging

Baggiano

Italiano

Guglielmo

et al. 2022

JCM

Self Cite

View full text Add to dashboard Cite

Coronary artery disease (CAD) represents the most common cardiovascular disease, with high morbidity and mortality. Historically patients with chest pain of suspected coronary origin have been assessed with functional tests, capable to detect haemodynamic consequences of coronary obstructions through depiction of electrocardiographic changes, myocardial perfusion defects or regional wall motion abnormalities under stress condition. Stress echocardiography (SE), single-photon emission computed tomography (SPECT), positron emission tomography (PET) and cardiovascular magnetic resonance (CMR) represent the functional techniques currently available, and technical developments contributed to increased diagnostic performance of these techniques. More recently, cardiac computed tomography angiography (cCTA) has been developed as a non-invasive anatomical test for a direct visualisation of coronary vessels and detailed description of atherosclerotic burden. Cardiovascular imaging techniques have dramatically enhanced our knowledge regarding physiological aspects and myocardial implications of CAD. Recently, after the publication of important trials, international guidelines recognised these changes, updating indications and level of recommendations. This review aims to summarise current standards with main novelties and specific limitations, and a diagnostic algorithm for up-to-date clinical management is also proposed.

show abstract

Section: Proposed Management Algorithm For Patient With Suspected Cadmentioning

confidence: 99%

Changing Paradigms in the Diagnosis of Ischemic Heart Disease by Multimodality Imaging

Baggiano

Italiano

Guglielmo

et al. 2022

JCM

Self Cite

View full text Add to dashboard Cite

show abstract

“…Cardiac CT has recently been increasingly used for functional testing [ 41 ]. CT angiography associated with CT perfusion (CTP) could have good performance in the assessment of microvascular disease.…”

Section: Cardiac Ctmentioning

confidence: 99%

Coronary Microvascular Dysfunction: PET, CMR and CT Assessment

Tonet

Pompei

Faragasso³

et al. 2021

JCM

View full text Add to dashboard Cite

Microvascular dysfunction is responsible for chest pain in various kinds of patients, including those with obstructive coronary artery disease and persistent symptoms despite revascularization, or those with myocardial disease without coronary stenosis. Its diagnosis can be performed with an advanced imaging technique such as positron emission tomography, which represents the gold standard for diagnosing microvascular abnormalities. In recent years, cardiovascular magnetic resonance and cardiac computed tomography have demonstrated to be emerging modalities for microcirculation assessment. The identification of microvascular disease represents a fundamental step in the characterization of patients with chest pain and no epicardial coronary disease: its identification is important to manage medical strategies and improve prognosis. The present overview summarizes the main techniques and current evidence of these advanced imaging strategies in assessing microvascular dysfunction and, if present, their relationship with invasive evaluation.

show abstract

“… Evaluation of the severity of coronary stenosis can be derived from estimating pressure differences via “virtual” fractional flow reserve derived from CCTA (FFR CT ). [83] CCTA can assess non-obstructive coronary artery plaque, which can inform CVD preventive management. Management decisions guided by CCTA in patients with stable chest pain may reduce CHD and MI mortality at 5 years, without prompting a higher rate of coronary angiography or coronary revascularization.…”

Section: Imaging Studiesmentioning

confidence: 99%

“…Evaluation of the severity of coronary stenosis can be derived from estimating pressure differences via “virtual” fractional flow reserve derived from CCTA (FFR CT ). [83] …”

Section: Imaging Studiesmentioning

confidence: 99%

Ten things to know about ten imaging studies: A preventive cardiology perspective (“ASPC top ten imaging”)

Bays

Khera

Blaha³

et al. 2021

American Journal of Preventive Cardiology

View full text Add to dashboard Cite

Knowing the patient's current cardiovascular disease (CVD) status, as well as the patient's current and future CVD risk, helps the clinician make more informed patient-centered management recommendations towards the goal of preventing future CVD events. Imaging tests that can assist the clinician with the diagnosis and prognosis of CVD include imaging studies of the heart and vascular system, as well as imaging studies of other body organs applicable to CVD risk. The American Society for Preventive Cardiology (ASPC) has published “Ten Things to Know About Ten Cardiovascular Disease Risk Factors.” Similarly, this “ASPC Top Ten Imaging” summarizes ten things to know about ten imaging studies related to assessing CVD and CVD risk, listed in tabular form. The ten imaging studies herein include: (1) coronary artery calcium imaging (CAC), (2) coronary computed tomography angiography (CCTA), (3) cardiac ultrasound (echocardiography), (4) nuclear myocardial perfusion imaging (MPI), (5) cardiac magnetic resonance (CMR), (6) cardiac catheterization [with or without intravascular ultrasound (IVUS) or coronary optical coherence tomography (OCT)], (7) dual x-ray absorptiometry (DXA) body composition, (8) hepatic imaging [ultrasound of liver, vibration-controlled transient elastography (VCTE), CT, MRI proton density fat fraction (PDFF), magnetic resonance spectroscopy (MRS)], (9) peripheral artery / endothelial function imaging (e.g., carotid ultrasound, peripheral doppler imaging, ultrasound flow-mediated dilation, other tests of endothelial function and peripheral vascular imaging) and (10) images of other body organs applicable to preventive cardiology (brain, kidney, ovary). Many cardiologists perform cardiovascular-related imaging. Many non-cardiologists perform applicable non-cardiovascular imaging. Cardiologists and non-cardiologists alike may benefit from a working knowledge of imaging studies applicable to the diagnosis and prognosis of CVD and CVD risk – both important in preventive cardiology.

show abstract

The Incremental Role of Coronary Computed Tomography in Chronic Coronary Syndromes

Cited by 18 publications

References 136 publications

Changing Paradigms in the Diagnosis of Ischemic Heart Disease by Multimodality Imaging

Changing Paradigms in the Diagnosis of Ischemic Heart Disease by Multimodality Imaging

Coronary Microvascular Dysfunction: PET, CMR and CT Assessment

Ten things to know about ten imaging studies: A preventive cardiology perspective (“ASPC top ten imaging”)

Contact Info

Product

Resources

About